Requiring, beginning on January 1, 2023, the Maryland Medical Assistance Program to provide gender-affirming treatment; and prohibiting the Program from issuing an adverse benefit determination related to gender-affirming treatment unless a health care provider with experience prescribing or delivering gender-affirming treatment has reviewed and confirmed the appropriateness of the determination.

Statutes affected:
Text - First - Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022): 15-103 Health General, 15-150 Health General, 2-024 Health General